Bravecto
Bravecto® chewable tablets for dogs
Bravecto Chewable Tablets is an ectoparasiticide treatment for dogs that contains the active ingredient fluralaner. It is a flea and tick treatment of the isoxazoline class for dogs with a duration of effect of 12 weeks*.
Bravecto is a pork-flavoured chewable tablet presented in child resistant, foil wrapped, pack of one tablet.
Indications for use
For the treatment of tick and flea infestations in dogs. This veterinary medicinal product is a systemic insecticide and acaricide that provides:
- immediate and persistent flea (Ctenocephalides felis) killing activity for 12 weeks,
- immediate and persistent tick killing activity for 12 weeks for Ixodes ricinus, Dermacentor reticulatus and D. variabilis,
- immediate and persistent tick killing activity for 8 weeks for Rhipicephalus sanguineus.
- persistent tick killing activity from 7 days to 12 weeks after treatment for Ixodes hexagonus.
Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
For the treatment of demodicosis caused by Demodex canis.
For the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation.
For reduction of the risk of infection with Babesia canis canis via transmission by Dermacentor reticulatus for up to 12 weeks. The effect is indirect due to product’s activity against the vector.
For reduction of the risk of infection with Dipylidium caninum via transmission by Ctenocephalides felis for up to 12 weeks. The effect is indirect due to product’s activity against the vector.